VANCOUVER, BC / ACCESS Newswire / November 19, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec” or the “Company”) is pleased to note today’s press release by HyProMag USA, LLC (“HyProMag USA”), its U.S.-based joint venture rare earth permanent magnet recycling and manufacturing company.
HyProMag USA announced it has extended its feedstock supply agreement with global electronics recycling company, Intelligent Lifecycle Solutions, LLC (“ILS”) (the “Supply Agreement”).
ILS is currently securing and storing neodymium iron boron (“NdFeB”) feedstock from hard disk drives (“HDDs”) at the ILS pre-processing sites in Williston, South Carolina and Reno, Nevada (the “ILS pre-processing sites”) in advance of the commissioning of HyProMag USA’s advanced stage rare earth magnet recycling and manufacturing plant to be located in Fort Worth, Texas.
In addition to HDDs, ILS will start to procure bulk NdFeB feedstock including rotors from electric motors, wind turbine magnets, speaker assemblies and MRIs. ILS and HyProMag USA have agreed to create a joint “Technical Procurement” team to accelerate all purchases and complete the onboarding of the INSERMA ANOIA S.L. (“Inserma”) “3rd generation” HDD magnet separation system at its sites. HyProMag USA is targeting delivery of the machines to the ILS pre-processing sites by the end of December 2025.
Julian Treger, Chief Executive of CoTec commented: “The ILS Supply Agreement continues to progress; multiple NdFeB feedstocks have been successfully tested through the accelerated piloting program at the University of Birmingham’s HPMS pilot facility which will support the technical procurement team as it continues to target and purchase bulk NdFeB feedstock sources across the United States. HyProMag USA is continuing to build long-term partnerships and work closely with commercial suppliers, federal and state governments to facilitate these feedstock sources.”
Graham Davy, ILS CEO commented: “ILS is excited to expand its procurement efforts to other NdFeB sources in partnership with HyProMag USA. The additional procurement and pre-processing operations will assist the recovery and recycling of critical strategic materials within the U.S. and provide a platform for further ILS growth. We look forward to working collaboratively with manufacturers and with their supply and vendor chains to facilitate the growth of rare earth material recycling using HyProMag’s innovative magnet recycling technology in the U.S.”
For further information, please refer to HyProMag USA’s press release, available at: www.hypromagusa.com
About HyProMag USA
HyProMag USA, LLC is owned 50:50 by CoTec Holdings Corp. (TSX-V:CTH)(OTCQB:CTHCF) and HyProMag Limited. HyProMag Limited is 100% owned by Maginito Limited which is owned on a 79.4%/20.6% basis by Mkango Resources Ltd. (MKA) and CoTec.
CoTec Holdings Corp. (TSX-V: CTH, OTCQB: CTHCF) is redefining the future of resource extraction and recycling. Focused on rare earth magnets and strategic materials, CoTec integrates breakthrough technologies with strategic assets to unlock secure, sustainable, and low-cost supply chains for the United States and its allies.
CoTec’s mission is clear: accelerate the energy transition while strengthening U.S. economic and national security. By investing in and deploying disruptive technologies, the Company delivers capital-efficient, scalable solutions that transform marginal assets, tailings, waste streams, and recycled products into high-value critical minerals.
From its HyProMag USA magnet recycling joint venture in Texas, to iron tailings reprocessing in Québec, to next-generation copper and iron solutions backed by global majors, CoTec is building a diversified portfolio with long-term growth, rapid cash flow potential, and high barriers to entry. The result is a game-changing platform at the intersection of technology, sustainability, and strategic materials.
Statements in this press release regarding the Company and its investments which are not historical facts are “forward-looking statements” which involve risks and uncertainties, including statements relating to the Company’s interest in and the proposed expansion of HyProMag USA and HyProMag USA’s relationship with ILS and management’s expectations with respect to its current and potential future investments, including HyProMag USA, and the benefits to the Company which may be implied from such statements. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements, due to known and unknown risks and uncertainties affecting the Company, including but not limited to resource and reserve risks; environmental risks and costs; labor costs and shortages; uncertain supply and price fluctuations in materials; increases in energy costs; labor disputes and work stoppages; leasing costs and the availability of equipment; heavy equipment demand and availability; contractor and subcontractor performance issues; worksite safety issues; project delays and cost overruns; extreme weather conditions; and social and transport disruptions. For further details regarding risks and uncertainties facing the Company please refer to “Risk Factors” in the Company’s filing statement dated April 6, 2022, a copy of which may be found under the Company’s SEDAR profile at www.sedar.com. The Company assumes no responsibility to update forward-looking statements in this press release except as required by law. Readers should not place undue reliance on the forward-looking statements and information contained in this news release and are encouraged to read the Company’s continuous disclosure documents which are available on SEDAR at www.sedarplus.ca.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVID
Company completed meeting with FDA October 2, 2025 for advice on possible expedited approval pathway to advance its ongoing placebo-controlled trial of crofelemer for potential approval for treatment of MVID
REMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q3 2025 financials and company updates; Click here to register
SAN FRANCISCO, CA / ACCESS Newswire / November 17, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today reported its consolidated third-quarter 2025 financial results.
2025 THIRD QUARTER COMPANY FINANCIAL RESULTS:
Net Revenue: The combined net revenue for the Company’s prescription products (Mytesi®, Gelclair®, and Canalevia®-CA1), including license revenue, was approximately $3.1 million in the third quarter of 2025, representing an increase of approximately 4% over the combined net revenue in the second quarter of 2025, which totaled approximately $3.0 million, and equaled the combined net revenue for the third quarter of 2024.
Mytesi Prescription Volume: Mytesi prescription volume increased by approximately 0.9% in the third quarter of 2025 over the second quarter of 2025, and Mytesi prescription volume in the third quarter of 2025 decreased by 3.6% compared to the volume in the third quarter of 2024. Prescription volume differs from invoiced sales volume, which reflects, among other factors, varying buying patterns among specialty pharmacies in the closed network as they manage their inventory levels.
License Revenue: For the third quarter of 2025, the Company recognized license fees of $42,858 from a securities purchase agreement with a European partner. As of September 30, 2025, the total deferred revenue associated with this contract amounts to approximately $595,000.
Neonorm™: Revenues for the non-prescription Neonorm products were minimal for the third quarters of 2025 and 2024.
Three Months Ending
Financial Highlights
September 30,
(in thousands, except per share amounts)
2025
2024
$ change
% change
Net product revenue
$
3,083
$
3,108
(25
)
-1
%
Loss from operations
$
(7,238
)
$
(7,262
)
24
0
%
Net loss attributable to common stockholders
$
(9,502
)
$
(9,854
)
352
-4
%
Net loss per share, basic and diluted
$
(6.28
)
$
(26.29
)
20
-76
%
Cost of Product Revenue: Total cost of product revenue decreased by approximately $0.01 million, from $0.54 million for the quarter ended September 30, 2024 compared to $0.53 million for the quarter ended September 30, 2025, due to a slight decrease in the average cost of Mytesi bottle lots.
Research and Development: The R&D expense decreased by $0.3 million, from $3.7 million for the quarter ended September 30, 2024 compared to $4.0 million for the quarter ended September 30, 2025, primarily due to the conclusion of the Phase 3 OnTarget clinical trial, which reduced trial-related contract manufacturing services and regulatory activities.
Sales and Marketing: The Sales and Marketing expense decreased by approximately $0.01 million, from $2.01 million for the quarter ended September 30, 2024 to approximately $2.0 million during the same quarter in 2025. Although personnel and related benefits, together with direct marketing fees, increased by $0.6 million, this was offset by decreased third-party consulting and other expenses of $0.7 million.
General and Administrative: The G&A expense increased by approximately $0.3 million, from $3.8 million for the quarter ended September 30, 2024 to $4.1 million during the same quarter in 2025, largely due to increased legal and compliance expenses from financing activities.
Loss from Operations: Loss from operations decreased by $0.1 million, from $7.2 million in the quarter ended September 30, 2024 to $7.3 million during the same period in 2025.
Net Loss: Net loss attributable to common shareholders decreased by approximately $0.4 million, from $9.9 million in the quarter ended September 30, 2024 to $9.5 million in the same period in 2025. In addition to the loss from operations:
Interest income (expense) decreased by $0.2 million, from approximately $0.2 million of interest income for the quarter ended September 30, 2024 to approximately $6,000 of interest expense in the same period in 2025, primarily due to changing the accounting of certain debt instruments designated at Fair Value Option (FVO).
The fair value of financial and hybrid instrument designation at FVO decreased by $0.8 million, from a loss of $3.1 million in the three months ended September 30, 2024, to a loss of $2.3 million in the same period in 2025, primarily due to fair value adjustments in liability classified warrants and notes payable designated at FVO.
Non-GAAP Recurring EBITDA: Non-GAAP recurring EBITDA for the third quarters of 2025 and 2024 were a net loss of $8.9 million and $8.9 million, respectively.
Three Months Ending
September 30,
(in thousands)
2025
2024
$ change
% change
(unaudited)
Net loss attributable to common stockholders
$
(9,502
)
$
(9,854
)
(352
)
4
%
Adjustments:
Interest income (expense)
6
(162
)
(168
)
104
%
Property and equipment depreciation
17
17
(0
)
-2
%
Amortization of intangible assets
463
457
(6
)
-1
%
Share-based compensation expense
135
305
170
56
%
Loss on extinguishment of debt
–
–
–
-100
%
Non-GAAP EBITDA
(8,881
)
(9,237
)
(357
)
4
%
Note Regarding Use of Non-GAAP Measures
The Company supplements its condensed consolidated financial statements presented on a GAAP basis by providing non-GAAP EBITDA and non-GAAP recurring EBITDA, which are considered non-GAAP under applicable SEC rules. Jaguar believes that the disclosure items of these non-GAAP measures provide investors with additional information that reflects the basis upon which Company management assesses and operates the business. These non-GAAP financial measures are not in accordance with GAAP and should not be viewed in isolation or as substitutes for GAAP net sales and GAAP net loss and are not substitutes for, or superior to, measures of financial performance in conformity with GAAP.
The Company defines non-GAAP EBITDA as net loss before interest expense and other expense, depreciation of property and equipment, amortization of intangible assets, share-based compensation expense and provision for or benefit from income taxes. The Company defines non-GAAP Recurring EBITDA as non-GAAP EBITDA adjusted for certain non-recurring revenues and expenses. Company management believes that non-GAAP EBITDA and non-GAAP Recurring EBITDA are meaningful indicators of Jaguar’s performance and provide useful information to investors regarding the Company’s results of operations and financial condition.
Participation Instructions for Webcast
When: Monday, November 17, 2025 at 8:30 a.m. Eastern
Participant Registration & Access Link: Click Here
Replay Instructions for Webcast
Replay of the webcast on the investor relations section of Jaguar’s website: (click here)
About Crofelemer
Crofelemer is the only oral FDA-approved prescription drug under botanical guidance. It is plant-based, extracted and purified from the red bark sap of the Croton lechleri tree in the Amazon Rainforest. Napo Pharmaceuticals, a Jaguar family company, has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for Indigenous communities.
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo’s crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.
Mytesi (crofelemer) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Mytesi is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting Mytesi. If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).
See full Prescribing Information at Mytesi.com. Crofelemer, the active ingredient in Mytesi, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.
About Gelclair®
INDICATIONS
GELCLAIR® has a mechanical action indicated for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies, including oral mucositis/stomatitis (may be caused by chemotherapy or radiation therapy), irritation due to oral surgery, traumatic ulcers caused by braces or ill-fitting dentures, or disease. Also, indicated for diffuse aphthous ulcers.
IMPORTANT SAFETY INFORMATION
Do not use GELCLAIR if there is a known or suspected hypersensitivity to any of its ingredients.
No adverse effects have been reported in clinical trials, although postmarketing reports have included infrequent complaints of burning sensation in the mouth.
If GELCLAIR is swallowed accidentally, no adverse effects are anticipated.
If no improvement is seen within 7 days, a physician should be consulted.
You are encouraged to report negative side effects of prescription medical products to the FDA.
For oral use in dogs only. Not for use in humans. Keep Canalevia-CA1 (crofelemer delayed-release tablets) in a secure location out of reach of children and other animals. Consult a physician in case of accidental ingestion by humans. Do not use in dogs that have a known hypersensitivity to crofelemer. Prior to using Canalevia-CA1, rule out infectious etiologies of diarrhea. Canalevia-CA1 is a conditionally approved drug indicated for the treatment of chemotherapy-induced diarrhea in dogs. The most common adverse reactions included decreased appetite, decreased activity, dehydration, abdominal pain, and vomiting.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Use only as directed. It is a violation of Federal law to use this product other than as directed in the labeling. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.
Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s expectation that it will hold an investor webcast on November 17, 2025, and Jaguar’s expectation that crofelemer can potentially extend lives of MVID patients, reducing the volume of the PS necessary for them to survive. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
MCLEAN, VA / ACCESS Newswire / November 17, 2025 / Gladstone Capital Corporation (Nasdaq:GLAD) (the “Company”) today announced earnings for its fourth quarter and fiscal year ended September 30, 2025. Please read the Company’s Annual Report on Form 10-K filed today with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov and the Investors section of the Company’s website at www.GladstoneCapital.com.
Summary Information (dollars in thousands, except per share data) (unaudited):
For the Quarter Ended:
September 30,
2025
June 30,
2025
Change
% Change
Total investment income
$
23,936
$
21,657
$
2,279
10.5
%
Total expenses, net of credits
(12,492
)
(10,363
)
(2,129
)
20.5
Net investment income
11,444
11,294
150
1.3
Net investment income per common share
0.52
0.50
0.02
4.0
Cash distribution per common share
0.59
0.50
0.09
18.0
Net realized gain (loss)
(6,258
)
(3,620
)
(2,638
)
72.9
Net unrealized appreciation (depreciation)
9,101
15
9,086
NM
Net increase (decrease) in net assets resulting from operations
13,971
7,448
6,523
87.6
Weighted average yield on interest-bearing investments
12.5
%
12.8
%
(0.3
)%
(2.3
)
Total invested
$
126,633
$
72,952
$
53,681
73.6
Total repayments and net proceeds
23,495
82,205
(58,710
)
(71.4
)
As of:
September 30,
2025
June 30,
2025
Change
% Change
Total investments, at fair value
$
859,124
$
751,260
$
107,864
14.4
%
Fair value, as a percent of cost
98.0
%
96.6
%
1.4
%
1.4
Net asset value per common share
$
21.34
$
21.25
$
0.09
0.4
NM- not meaningful
For the Year Ended:
September 30, 2025
September 30,
2024
Change
% Change
Total investment income
$
89,122
$
96,621
$
(7,499
)
(7.8
)%
Total expenses, net of credits
(43,915
)
(50,562
)
(6,647
)
(13.1
)
Net investment income
45,207
46,059
(852
)
(1.8
)
Net investment income per common share
2.02
2.11
(0.09
)
(4.3
)
Cash distribution per common share
2.48
1.98
0.50
25.3
Net realized gain (loss)
55,642
5,959
49,683
NM
Net unrealized appreciation (depreciation)
(42,739
)
42,703
(85,442
)
NM
Net increase (decrease) in net assets resulting from operations
57,191
94,506
(37,315
)
(39.5
)
Weighted average yield on interest-bearing investments
12.7
%
13.9
%
(1.2
)%
(8.6
)
Total invested
$
396,796
$
177,649
$
219,147
123.4
Total repayments and proceeds
352,317
136,270
216,047
158.5
As of:
September 30, 2025
September 30,
2024
Change
% Change
Total investments, at fair value
$
859,124
$
796,260
$
62,864
7.9
%
Fair value as a percent of cost
98.0
%
103.3
%
(5.3
)%
(5.1
)
Net asset value per common share
$
21.34
$
21.18
$
0.16
0.8
NM- not meaningful
Fourth Fiscal Quarter 2025 Highlights:
Portfolio Activity: Invested $106.7 million in five new portfolio companies and $19.9 million in existing portfolio companies.
Portfolio Mix: Secured first lien assets continue to be over 70% of our debt investments, at cost.
Debt Issuance: Issued our 5.875% Convertible Notes, due 2030 (the “2030 Convertible Notes”), for gross proceeds of $149.5 million.
Fourth Fiscal Quarter 2025 Results:
Total investment income increased by $2.3 million, or 10.5%, for the quarter ended September 30, 2025, compared to the prior quarter ended June 30, 2025, driven primarily by a $2.9 million increase in interest income, quarter over quarter, partially offset by a $0.6 million decrease in other income. Interest income increased by $2.9 million, or 14.0%, quarter over quarter, primarily due to an increase in the weighted average principal balance of our interest-bearing investment portfolio to $752.0 million during the quarter ended September 30, 2025 as compared to $647.2 million during the quarter ended June 30, 2025. This increase was offset by a decrease in the weighted average yield to 12.5% during the quarter ended September 30, 2025 as compared to 12.8% during the quarter ended June 30, 2025. The decrease in other income was driven by decreases in dividend income and prepayment fee income quarter over quarter.
Total expenses increased by $2.1 million, or 20.5%, quarter over quarter, primarily due to a $1.3 million increase in interest expense and a $0.9 million increase in the net incentive fee quarter over quarter. The quarter over quarter increase in interest expense was driven by a $0.9 million increase in interest expense on our Credit Facility and a $0.5 million increase in interest expense on our notes payable. The $0.9 million increase in interest expense on our Credit Facility was driven by increased borrowings; the weighted average balance outstanding on our Credit Facility for the quarter ended September 30, 2025 was $74.3 million, as compared to $6.6 million for the quarter ended June 30, 2025, an increase of $67.7 million quarter over quarter. The $0.5 million increase in interest expense on our notes payable was driven by the issuance of the 2030 Convertible Notes in September 2025. The quarter over quarter increase in the net incentive fee was driven by decreased credits to the incentive fee. These increases were partially offset by a $0.4 million decrease in the net base management fee, driven by higher investment banking fee credits to the base management fee from increased deal originations.
Net investment income for the quarter ended September 30, 2025 was $11.4 million, or $0.52 per share.
The net increase in net assets resulting from operations was $14.0 million, or $0.63 per share, for the quarter ended September 30, 2025, compared to $7.4 million, or $0.33 per share, for the quarter ended June 30, 2025. The current quarter increase in net assets resulting from operations was primarily driven by $11.4 million of net investment income and $9.1 million of net unrealized appreciation during the quarter, partially offset by $6.3 million of net realized loss recognized during the quarter.
Fiscal Year Ended 2025 Results:
Total investment income during the years ended September 30, 2025 and 2024 was $89.1 million and $96.6 million, respectively. The year over year decrease was primarily due to a $6.0 million decrease in interest income and a $1.5 million decrease in other income. The decrease in interest income was driven by a decrease in the weighted average yield of our interest-bearing investment portfolio from 13.9% during the year ended September 30, 2024 to 12.7% during the year ended September 30, 2025. This decrease was partially offset by an increase in the weighted average principal balance of our interest-bearing investment portfolio of $15.6 million, or 2.3%, year over year. The decrease in other income was driven primarily by a decrease of $0.9 million in dividend income and a decrease of $0.4 million in success fees received.
Expenses, net of any non-contractual, unconditional and irrevocable credits to fees from the Adviser, decreased $6.6 million, or 13.1%, for the year ended September 30, 2025, as compared to the prior year. This decrease was primarily due to a $3.1 million decrease in the net incentive fee, a $2.4 million decrease in the net base management fee, and a $1.7 million decrease in interest expense.
Net investment income for the year ended September 30, 2025 was $45.2 million, a decrease of 1.8%, as compared to the prior year, or $2.02 per share.
The net increase in net assets resulting from operations was $57.2 million, or $2.56 per share, for the year ended September 30, 2025, compared to $94.5 million, or $4.34 per share, for the year ended September 30, 2024. The current year increase was driven by net investment income of $45.2 million and net realized gains of $55.6 million, partially offset by $42.7 million in net unrealized depreciation.
Subsequent Events: Subsequent to September 30, 2025, the following significant events occurred:
Portfolio Activity:
In October 2025, we invested $11.0 million in Total Access Elevator, LLC (“Total Access”), an existing portfolio company, through secured first lien debt. We also extended Total Access a new $9.85 million delayed draw term loan commitment, which was unfunded at close.
In October 2025, our $28.1 million debt investment in Leadpoint Business Services, LLC paid off at par. We also received a $0.3 million prepayment penalty in conjunction with the payoff.
In October 2025, the sale of our remaining common equity investment in Sokol and Company, LLC was completed, representing a return of our equity cost basis of $0.5 million and a realized gain of approximately $1.8 million.
In October 2025, our debt investment in Sea Link International IRB, Inc. (“Sea Link”) paid off at par. We also received a $0.2 million exit fee in conjunction with the payoff. We continue to hold common and preferred equity in Sea Link.
In November 2025, we invested $15.0 million in Turn Key Health Clinics, LLC, an existing portfolio company, through secured first lien debt.
In November 2025, we invested $26.6 million in Sicilian Oven Restaurants LLC through secured first lien debt and preferred equity.
Debt Redemption:
In October 2025, we voluntarily redeemed our 7.75% Notes, due 2028, with an aggregate principal amount of $57.0 million.
In October 2025, we voluntarily redeemed our 5.125% Notes, due 2026, with an aggregate principal amount of $150.0 million.
Distributions and Dividends Declared:
In October 2025, our Board of Directors declared the following distributions to common and preferred stockholders:
Record Date
Payment Date
Distribution per Common Share
October 24, 2025
October 31, 2025
$
0.15
November 17, 2025
November 26, 2025
0.15
December 22, 2025
December 31, 2025
0.15
Total for the Quarter
$
0.45
Record Date
Payment Date
Distribution per Series A Preferred Stock
October 27, 2025
November 5, 2025
$
0.130208
November 25, 2025
December 5, 2025
0.130208
December 29, 2025
January 5, 2026
0.130208
Total for the Quarter
$
0.390624
Comments from Gladstone Capital’s President, Bob Marcotte: “FY25 closed on a high note as our lower middle market investment focus produced over $100 million of net originations, and we reset near term maturities and increased our floating rate funding via the debt refinancing concluded shortly after 9/30. These actions combined with our modest leverage have positioned us well to deliver continued asset growth and sustain our net interest income in support of future shareholder distributions.”
Conference Call for Stockholders: The Company will hold its earnings release conference call on Tuesday, November 18, 2025, at 8:30 a.m. Eastern Time. Please call (866) 424-3437 to enter the conference call. An operator will monitor the call and set a queue for any questions. A replay of the conference call will be available through November 25, 2025. To hear the replay, please dial (877) 660-6853 and use playback conference number 13755536. The replay of the conference call will be available beginning approximately one hour after the call concludes. The live audio broadcast of the Company’s quarterly conference call will also be available online at www.GladstoneCapital.com. The event will be archived and available for replay on the investors section of the Company’s website.
About Gladstone Capital Corporation: Gladstone Capital Corporation is a publicly-traded business development company that invests in debt and equity securities, consisting primarily of secured first and second lien term loans to lower middle market businesses in the United States. Information on the business activities of Gladstone Capital and the other publicly-traded Gladstone funds can be found at www.GladstoneCompanies.com.
To obtain a paper copy of the Company’s most recent Form 10-K, please contact the Company at 1521 Westbranch Drive, Suite 100, McLean, VA 22102, ATTN: Investor Relations. The financial information above is not comprehensive and is without notes, so readers should obtain and carefully review the Company’s Form 10-K for the year ended September 30, 2025, including the notes to the consolidated financial statements contained therein.
The statements in this press release about future growth and shareholder returns are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on our current plans that are believed to be reasonable as of the date of this press release, a number of factors could cause actual results and conditions to differ materially from these forward-looking statements, including those factors described from time to time in our filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or otherwise, except as required by law.
The one-night event, called “Hope for America,” aimed to bring hope to a community shocked by Charlie Kirk’s assassination
OREM, UT / ACCESS Newswire / November 18, 2025 / Thousands gathered at Utah Valley University’s UCCU Center for an unforgettable evening of worship, inspiration and community during the latest Harvest Crusade hosted by Pastor Greg Laurie. The one-night event, themed “Hope for America,” featured powerful performances from award-winning Christian artists Chris Tomlin and Phil Wickham.
Pastor Greg Laurie Greg Laurie stands behind the pulpit at the Harvest Crusade: Hope for America at Utah Valley University
Originally planned for 2027, the Harvest Crusade was hastened by the tragic Sept. 10 assassination of Charlie Kirk on the campus of Utah Valley University. “When we heard of Charlie Kirk’s assassination,” Laurie said, “we immediately reached out to pastors in Utah to ask how we could support them. They said, ‘Come sooner. Our community is hurting.’”
The Harvest Crusade brought together attendees from across the region, as well as 1000 volunteers, with 67 churches in surrounding areas serving as remote overflow sites. In addition, hundreds of media partners streamed the event nationally, including over 600 radio stations.
The evening opened with a moving tribute video honoring the life and legacy of Charlie Kirk, setting the tone for a night centered on hope and bold faith.
“Despite this tragedy, God has done amazing things around our nation and people are asking questions. . . . It was like a wakeup call,” Laurie said. “This is your moment tonight. This is your wakeup call tonight. Don’t let it slip by.”
The event concluded with an invitation for attendees to make a personal commitment to faith as artist Phil Wickham sang “Oh Come to the Altar.” By the end of the evening, over 2,100 people had made professions of faith in person and online.
“I was there at UVU on [Sept. 10] and witnessed the murder,” said one attendee. “Seeing the UCCU arena filled with people who were hungry to heal was amazing. The altar call broke me with joyful tears… Healed and peaceful are two words I now identify with.”
Event Highlights:
Venue Attendance: 7,800
Livestream Views: 210,000
Professions of Faith: 2,100+
Participating churches: 67
“Our one-night event at UVU in Utah was an astounding success! The people were so open, worshipful, and responsive to the gospel. Many came to Christ,” Laurie said.
The Harvest Crusade at Utah Valley University marks another milestone in Pastor Greg Laurie’s over-35-year ministry of large-scale evangelistic events. Harvest Crusades are large-scale evangelistic events with a worldwide history spanning the United States, Canada, New Zealand and Australia. Since 1990, more than six million people have attended Harvest Crusades in person, in addition to the millions more that have participated online. Cumulatively, more than 600,000 individuals have made professions of faith through the Harvest Crusades.
MEDIA: High-quality photos of the Harvest Crusade are available here.
For more information about upcoming Harvest events, visit https://harvest.org.
Greg Laurie is the founder of the Harvest Crusades and senior pastor of Harvest Church, with campuses located in California and Hawaii. He is a renowned evangelist, bestselling author and inspiration for the 2023 “Jesus Revolution” film. He leads annual Harvest Crusades, large-scale evangelistic events that share the gospel with thousands in stadiums worldwide.
Action Air Duct, a Denver-based air duct cleaning company, has announced enhanced cleaning protocols specifically designed to address the unique challenges posed by Colorado’s wildfire season and the resulting smoke particle contamination in residential and commercial HVAC systems.
The company has developed specialized techniques to remove wildfire ash and smoke particles that become trapped in ductwork during Colorado’s increasingly active fire seasons. These microscopic particles can remain in HVAC systems long after outdoor air quality improves, continuing to circulate throughout homes and businesses with each heating and cooling cycle.
“Wildfire smoke contains extremely fine particles that penetrate deep into ductwork and can persist for months or even years without professional removal,” said Tamir Bachner of Action Air Duct. “Our enhanced protocols use negative pressure systems combined with HEPA filtration to ensure complete removal of these harmful contaminants, protecting families from ongoing exposure to smoke-related pollutants.”
The Denver metro area has experienced increased wildfire smoke exposure in recent years, with particles from both local and distant fires affecting indoor air quality. Traditional air filters cannot capture all smoke particles, which range from 0.4 to 0.7 microns in size. These particles settle throughout duct systems and continue recirculating long after fires are extinguished.
Action Air Duct Cleaning employs video inspection technology to identify areas where smoke particles accumulate most heavily. The company’s technicians use specialized equipment designed to dislodge and capture these particles without releasing them back into living spaces. The process includes antimicrobial treatments that prevent secondary issues such as mold growth in contaminated ductwork.
Colorado’s unique environmental factors compound the challenge of maintaining clean air ducts. The state’s high altitude affects air circulation patterns, while its dry climate increases static buildup that attracts and holds dust particles. Temperature extremes between seasons cause ductwork to expand and contract, potentially creating gaps where contaminants enter.
The company reports that professional duct cleaning can reduce respiratory triggers by up to 80 percent, particularly important for households with members suffering from asthma, allergies, or other respiratory conditions. Clean ductwork also improves HVAC efficiency by up to 25 percent, reducing energy costs and extending equipment lifespan.
Beyond wildfire smoke, the enhanced protocols address other regional air quality challenges including construction dust from Denver’s building boom, seasonal pollen, and debris from Front Range dust storms. The comprehensive cleaning process removes accumulated contaminants that standard maintenance cannot reach.
Action Air Duct serves residential and commercial clients throughout the Denver metro area, including Arvada, Aurora, Boulder, Castle Rock, Centennial, Englewood, Golden, Highlands Ranch, Lakewood, Littleton, Parker, Thornton, and Westminster. The family-owned company has operated since 2014, maintaining a focus on professional service and customer satisfaction. The company provides air duct cleaning, dryer vent cleaning and installation, furnace cleaning, HVAC repair and maintenance, and range hood installation services to help maintain healthy indoor environments across Colorado’s Front Range.
###
For more information about Action Air Duct, contact the company here:
Action Air Duct Tamir Bachner 720-257-3319 tamir@actionairduct.net 100 Fillmore St Suite 563 Denver, CO 80206
Scientific Restoration Specialists Inc., a Lancaster-based restoration company, is highlighting its distinctive restoration-first methodology that prioritizes repairing and restoring damaged property rather than defaulting to replacement. This approach addresses growing concerns among property owners about the time, cost, and disruption associated with traditional disaster recovery methods.
The company’s restoration-focused strategy represents a departure from conventional practices in the industry, where replacement often becomes the default solution for water damage restoration and other property disasters. By emphasizing repair and restoration of existing materials and belongings, the company reports achieving faster project completion times while reducing overall costs for property owners.
The restoration-first approach utilizes advanced technology, including the Esporta cleaning system, which can restore items damaged by smoke, soot, and other contaminants that might otherwise be discarded. This technology, combined with ultrasonic cleaning techniques, enables the recovery of contents that traditional methods would deem unsalvageable.
“The Scientific Restoration Difference lies in our commitment to preserving what matters most to property owners,” said Kyle Herndon, spokesperson for Scientific Restoration Specialists Inc. “When disaster strikes, whether from water, fire, or mold damage, our first instinct isn’t to tear everything out and start over. We evaluate what can be saved and restored, which often surprises clients who assume their belongings are total losses.”
For property owners facing water damage restoration challenges, the company’s methodology offers several advantages. The process begins with a thorough initial assessment to determine which materials and belongings can be restored. This is followed by specialized mitigation techniques, water extraction, and targeted drying and dehumidification processes designed to preserve existing structures and contents.
The company maintains IICRC certifications in water, mold, and fire restoration, ensuring adherence to industry standards while implementing its restoration-focused approach. With over 19 years of experience serving Southern California communities, the team has developed expertise in evaluating and restoring properties affected by various types of damage.
“Property owners often don’t realize how much can actually be saved after a disaster,” added Herndon. “Our restoration teams regularly recover family heirlooms, important documents, and structural elements that clients assumed were destroyed. This not only reduces replacement costs but also preserves items with irreplaceable sentimental value.”
The restoration-first methodology also addresses environmental concerns by reducing waste sent to landfills and minimizing the resources required for manufacturing replacement materials. This approach aligns with growing awareness about sustainable practices in the construction and restoration industries.
Scientific Restoration Specialists Inc. provides comprehensive restoration services, including water damage restoration, fire damage restoration, mold removal, sewage cleanup, and specialized drying services. The company operates with 24/7 emergency response capabilities and works directly with insurance companies to streamline the claims process for property owners. As a locally owned business based in Lancaster, California, the company serves residential and commercial properties throughout Southern California, offering free inspections and specialized discounts for military personnel and seniors.
###
For more information about Scientific Restoration Specialists Inc., contact the company here:
Scientific Restoration Specialists Inc. Kyle Herndon (661) 213-8400 claims@srsav.com 2010 W Ave K #465, Lancaster, CA 93536
New U.S. research from the Family Online Safety Institute reveals how older teens are using, understanding, and feeling about generative AI
WASHINGTON, D.C. / ACCESS Newswire / November 18, 2025 / As generative AI transforms everyday life, a new study from the Family Online Safety Institute (FOSI) shows how older teens are engaging with these tools and what they see as the benefits and risks.
The report, Generative AI and Uncertain Times: How Teens Are Navigating a New Digital Frontier, focuses on teens ages 15 to 18 and their use of generative AI tools. Based on focus group discussions and a national survey of 1,000 U.S. teen generative AI users, the study provides an early look at how the next generation relates to this technology at school, at home, and in social settings.
“Generative AI is reshaping how young people learn, create, and communicate,” said Alanna Powers-O’Brien, co-author of the report “This research highlights both opportunity and challenge. Teens are curious and resourceful, and they need clear guidance, responsible design, and a voice in shaping the digital future.”
Key Findings
45% of teen generative AI users engage with these tools more than once a week.
Convenience (30%) and speed (18%) are the most cited benefits.
Concerns about generative AI are relatively evenly distributed. Loss of critical thinking skills (19%) is the top concern, followed by impact on future generations (15%).
42% have talked about their feelings with a generative AI chatbot.
60% say they feel safe while using generative AI, but 44% say generative AI’s behaviors “freak them out.”
54% believe young people should be involved in the design of GenAI tools.
57% report that their parents do not have rules about GenAI use.
The data reveal differences by gender and identity. Teen girls are more likely to worry about generative AI’s potential erosion of critical thinking skills, but are also more likely to value its convenience. Teen boys are more likely to see accuracy as a benefit of the technology, but worry about potential impacts on the job market. LGBTQ+ teens are more likely to talk about their feelings with chatbots. Members of this community also tend to have greater privacy and safety concerns.
Global Implications
Findings point to practical steps for key stakeholders:
Parents: Start open conversations, set household boundaries, and learn alongside teens.
Industry: Design with youth, not just for them. Make safety, transparency, and privacy the default.
Policymakers: Use evidence-based approaches that balance innovation and protection. Establish baseline standards and invest in media and digital literacy.
“Understanding how teens think and feel about generative AI is essential to building the right policies and protections,” said Andrew Zack, Senior Policy Manager. “Their perspectives can guide more thoughtful, inclusive, and effective solutions.”
About the Research
This mixed-methods study includes four focus groups, three youth reflection sessions, and a national survey of 1,000 U.S. teens who used generative AI in the past six months. Qualitative data collection was conducted with In Tandem. Quantitative data collection was conducted by TeenVoice.
About the Family Online Safety Institute
The Family Online Safety Institute (FOSI) unites leaders in industry, government, and the nonprofit sector to create solutions that promote a safer and more positive digital world for children and families. Through research, resources, and advocacy, FOSI works globally to make the online world safer for kids and families. Learn more at www.fosi.org.
New city-led programs in Portland and Santa Monica highlight the next phase of the national initiative driving innovation in wood construction.
OREGON CITY, OR / ACCESS Newswire / November 18, 2025 / The Softwood Lumber Board (SLB), in partnership with the USDA Forest Service (Forest Service), is expanding its Accelerator Cities Program to advance affordable, sustainable building solutions through wood construction. Building on successful collaborations in Boston, Georgia, and New York City, the next phase of the initiative introduces new city-led programs in Portland, Oregon, and Santa Monica, California.
Launched to help cities pilot and scale low-carbon building approaches, the Accelerator Cities Program provides funding, technical support, and peer learning to drive innovation in wood design and construction. Each city’s program focuses on improving housing access, reducing embodied carbon, and strengthening local economies through wood-based development.
City of Portland – Pilot Mass Timber Feasibility Studies Grant Program
The City of Portland Housing Bureau (PHB) has launched a Pilot Mass Timber Feasibility Studies Grant Program to explore how mass timber construction can support the city’s sustainability goals and affordable housing priorities. With $450,000 in combined funding from the SLB, Forest Service, and PHB, the program will support several active development projects that test the feasibility and benefits of using mass timber in multifamily housing and related commercial projects. Beginning in 2026, selected project teams will complete feasibility studies comparing design, cost, and carbon performance between mass timber and conventional building materials.
The initiative builds on Portland’s goal to achieve carbon neutrality by 2050 and reflects the city’s leadership in advancing sustainable, high-performance building solutions. Findings from the pilot will inform future policy updates, workforce development opportunities, and broader strategies for affordable, low-carbon housing, with an eye towards future support for mass timber construction.
City of Santa Monica – Santa Monica Mass Timber Accelerator
The City of Santa Monica is launching the Santa Monica Mass Timber Accelerator, a new initiative designed to evaluate and expand the use of sustainable building materials across local development projects. Backed by $115,000 in total funding from the SLB, Forest Service, and the City, the program will award competitive grants to design teams conducting early-phase feasibility studies on the use of mass timber in residential, commercial, and institutional construction.
Through public events, technical assistance, and industry collaboration, the program will raise awareness of mass timber’s environmental and economic benefits while fostering connections among architects, developers, and community leaders. Supported by national and local partners, the initiative will also assess opportunities for workforce growth and carbon reduction within Santa Monica’s building sector.
Running from November 2025 through March 2027, the program aligns with the city’s broader sustainability and housing goals by promoting innovative, lower-carbon approaches to construction and development.
—
“Each city we partner with brings new insights into how mass timber can help meet housing, sustainability, and economic goals,” said Cees de Jager, President and CEO of the Softwood Lumber Board. “Through the Accelerator Cities Program, we’re helping local leaders and building professionals demonstrate that wood construction is not only viable-it’s a scalable solution for sustainable, affordable development.”
“In the midst of an ongoing housing crisis, Portland is eager to support innovative housing development strategies,” said Portland Deputy City Administrator for Community & Economic Development, Donnie Oliveira. “Mass timber represents a unique opportunity to fuse environmental sustainability, workforce development, and faster, more affordable housing development. Portland is grateful to the Softwood Lumber Board and the US Forest Service for partnering with us to move this critical work forward.”
“The City of Santa Monica is proud to continue our tradition as a leader in sustainability and demonstrate our commitment to innovation,” said Chief Sustainability Officer for the City of Santa Monica, Shannon Parry. “The mass timber accelerator is an exciting opportunity to showcase how sustainability can be a catalyst to reach our economic development and housing goals.”
—
About the Accelerator Cities Program
The Accelerator Cities Program is a national initiative of the SLB and Forest Service designed to help cities pilot and scale sustainable wood building systems. Through direct project funding, technical assistance, and peer exchange, the program supports city-led innovation in housing, sustainability, and community development. Visit softwoodlumberboard.org/accelerator-cities-program for more information.
—
About the Softwood Lumber Board
The Softwood Lumber Board (SLB) is an industry-funded initiative established to promote the benefits and uses of softwood lumber products in outdoor, residential, and non-residential construction. The SLB invests in strategic programs and initiatives that drive demand and grow markets for softwood lumber products in the United States.
—
About the Forest Service Established in 1905, the Forest Service, an agency of the U.S. Department of Agriculture, is the nation’s foremost federal forestry organization. The agency is a world leader in forest research, providing leadership in the sustainable management, conservation, use, and stewardship of natural and cultural resources on national forests and grasslands in the United States.
Dedicated Forest Service employees manage the National Forest System, which consists of 154 national forests and 20 national grasslands covering 193 million acres in 43 states, the Virgin Islands, and Puerto Rico. The agency’s renowned fire management organization provides critical expertise in making communities and infrastructure safer. Moreover, the agency helps communities; state, local, and tribal governments; forest industries; and private forest landowners improve conditions in both urban and rural areas. In total, the Forest Service helps to steward about 900 million forested acres in the U.S., including 130 million acres in urban areas, which most Americans now call home.
Pediatric Eye Specialists, a North Texas-based ophthalmology practice dedicated to pediatric vision care, has published a new educational article, “Vision-Related Learning Problems,” addressing one of the most frequently overlooked causes of academic struggles in children: undiagnosed vision issues. The article brings attention to how children who appear to have learning or attention problems may, in fact, be struggling with visual disorders that impact reading, writing, focus, and comprehension—even when standard eye tests show 20/20 vision.
According to Pediatric Eye Specialists, as many as one in four school-aged children may have a vision problem that affects learning. These issues often go unnoticed because most school-based screenings check only for visual acuity, not for how well the eyes work together or how efficiently the brain processes visual information. The article emphasizes that when a child’s visual system does not function properly, it can affect nearly every aspect of classroom performance—from reading fluency to handwriting and math comprehension.
The new release, available on the Pediatric Eye Specialists website, outlines four major categories of vision-related learning problems: refractive errors, binocular vision disorders, functional vision problems, and visual perception problems. Each can interfere with a child’s academic performance in different ways. Refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), and astigmatism distort visual clarity, while binocular vision disorders—such as amblyopia and strabismus—disrupt how both eyes align and work together. Functional vision problems affect how the eyes move and focus, leading to eye strain, headaches, and trouble reading. Visual perception problems, meanwhile, involve how the brain interprets what the eyes see, influencing spatial awareness, memory, and organization on the page.
“Many parents assume that if their child passes a vision screening, vision isn’t the issue,” said Dr. Eric Packwood, pediatric ophthalmologist at Pediatric Eye Specialists. “But vision is more than seeing clearly—it’s how the eyes and brain coordinate complex visual tasks required for learning. Identifying and treating these issues early can make a profound difference in a child’s academic confidence and long-term success.”
The article also details how vision problems can mimic or exacerbate conditions such as attention deficit hyperactivity disorder (ADHD). Children experiencing eye strain or blurred vision may appear distracted, restless, or unmotivated, when in fact they are simply struggling to process what they see. These challenges can lead to frustration, avoidance of reading tasks, and even behavioral issues in the classroom. Pediatric Eye Specialists notes that comprehensive pediatric eye exams—beyond basic screenings—can help distinguish between true learning disabilities and vision-related barriers.
In addition to outlining the causes and symptoms of vision-related learning problems, the article explains how these issues are diagnosed and treated. Comprehensive testing performed by pediatric ophthalmologists evaluates not only clarity of vision but also eye teaming, tracking, focusing, and visual processing. Treatment may include prescription glasses, corrective lenses for near work, or vision therapy designed to strengthen eye coordination and focusing skills. Early intervention can help prevent academic setbacks and restore confidence for children who may otherwise be mislabeled as inattentive or struggling learners.
Dr. Packwood added, “Our goal is to identify the root cause of a child’s academic difficulty rather than simply addressing the symptoms. When vision challenges are corrected, parents and teachers often notice remarkable improvements in reading fluency, attention, and overall classroom engagement.”
The article underscores that many signs of vision-related learning problems are subtle. Children may experience headaches, eye strain, or fatigue after reading, skip lines while reading aloud, or have poor handwriting and difficulty copying from the board. These symptoms often go unrecognized or mistaken for lack of effort. Pediatric Eye Specialists encourages parents to seek evaluation if their child exhibits these signs, particularly when traditional educational interventions have not improved performance.
The publication also distinguishes between learning disabilities and vision-related problems, clarifying that the former involves neurological processing while the latter relates to how the eyes and brain coordinate visual input. Understanding this difference helps educators and families pursue the most appropriate support for each child. Pediatric Eye Specialists continues to advocate for comprehensive eye exams as a standard part of developmental and academic evaluations.
Serving families across Fort Worth, Denton, Mansfield, Prosper, and Keller, Pediatric Eye Specialists provides specialized pediatric ophthalmology care focused on early detection and intervention. The practice’s multidisciplinary approach combines medical expertise with compassion, ensuring every child receives the support needed to reach their visual and academic potential.
“Vision-Related Learning Problems” serves as both an educational resource for parents and a call to action for educators, pediatricians, and journalists to highlight the critical connection between healthy vision and learning success. Reporters interested in covering pediatric eye health or scheduling an interview with Dr. Packwood are invited to contact Pediatric Eye Specialists’ media office for additional information and data resources.
###
For more information about Pediatric Eye Specialists, contact the company here:
Pediatric Eye Specialists Dawn Lamb info@pediatriceyespecialists.com Pediatric Eye Specialists 321 S Henderson St. Fort Worth, TX 76104
TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20, 2025.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ:WGRX) is pharmacy physical and technology enabling health IT company that specializes in optimizing the delivery medications from manufacturers to patients. Its integrated platform connects 6,500+ pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in U.S. healthcare.
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health’s strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially. Additional factors are discussed in Wellgistics Health’s filings with the SEC, available at www.sec.gov.
Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, NY 10036 Office: (646) 893-5835 Email: info@skylineccg.com
